Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jul 1;119(13):2399-404.
doi: 10.1002/cncr.27941. Epub 2013 May 13.

Agent Orange as a risk factor for high-grade prostate cancer

Nathan Ansbaugh  1 , Jackilen Shannon, Motomi Mori, Paige E Farris, Mark Garzotto
Affiliations

Agent Orange as a risk factor for high-grade prostate cancer

Nathan Ansbaugh et al. Cancer. .

Abstract

Background: Agent Orange (AO) exposure (AOe) is a potential risk factor for the development of prostate cancer (PCa). However, it is unknown whether AOe specifically increases the risk of lethal PCa. The objective of this study was to determine the association between AOe and the risk of detecting high-grade PCa (HGPCa) (Gleason score ≥7) on biopsy in a US Veteran cohort.

Methods: Risk factors included clinicodemographic and laboratory data from veterans who were referred for an initial prostate biopsy. Outcomes were defined as the presence versus the absence of PCa, HGPCa, or low-grade PCa (LGPCa) (Gleason score ≤6) in biopsy specimens. Risk among AOe veterans relative to unexposed veterans was estimated using multivariate logistic regression. Separate models were used to determine whether AOe was associated with an increased risk of PCa, HGPCa, or LGPCa.

Results: Of 2720 veterans who underwent biopsy, PCa was diagnosed in 896 veterans (32.9%), and 459 veterans (16.9%) had HGPCa. AOe was associated with a 52% increase in the overall risk of detecting PCa (adjusted odds ratio, 1.52; 95% confidence interval, 1.07-2.13). AOe did not confer an increase in the risk of LGPCa (adjusted odds ratio, 1.24; 95% confidence interval, 0.81-1.91), although a 75% increase in the risk of HGPCa was observed (adjusted odds ratio, 1.75; 95% confidence interval, 1.12-2.74). AOe was associated with a 2.1-fold increase (95% confidence interval, 1.22-3.62; P < .01) in the risk of detecting PCa with a Gleason score ≥8.

Conclusions: The current results indicated that an increased risk of PCa associated with AOe is driven by an increased risk of HGPCa in men who undergo an initial prostate biopsy. These findings may aid in improved PCa screening for Vietnam-era veterans.

PubMed Disclaimer

References

    1. Group UCSW. United States Cancer Statistics: 1999–2005 Incidence and Mortality Web-based Report. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2009.
    1. Bill-Axelsson A. Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer. The New England Journal of Medicine. 2005;352(19):1977–1984. - PubMed
    1. Andriole G, et al. Mortality Results from a Randomized Prostate-Cancer Screening Trail. The New England Journal of Medicine. 2009;360(13):1310–1319. - PMC - PubMed
    1. Schroder S, et al. Screening and Prostate-Cancer Mortality in a Randomized European Study. The New England Journal of Medicine. 2009;360(13):1320–1328. - PubMed
    1. Moyer VA. Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement. Annals of Internal Medicine. 2012;157(2):1–16. - PubMed

MeSH terms